Page last updated: 2024-09-04

ml-3000 and pha 408

ml-3000 has been researched along with pha 408 in 1 studies

Compound Research Comparison

Studies
(ml-3000)
Trials
(ml-3000)
Recent Studies (post-2010)
(ml-3000)
Studies
(pha 408)
Trials
(pha 408)
Recent Studies (post-2010) (pha 408)
13095616010

Protein Interaction Comparison

ProteinTaxonomyml-3000 (IC50)pha 408 (IC50)
Inhibitor of nuclear factor kappa-B kinase subunit betaHomo sapiens (human)0.0133

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1

Other Studies

1 other study(ies) available for ml-3000 and pha 408

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013